Safinamide vs Co-beneldopa (Benserazide/levodopa)
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 20.0× as often as Safinamide in March 2026 — 79,414 items versus 3,967 in England.
3,967items
Safinamide · March 2026
NHSBSA Prescription Cost Analysis
79,414items
Co-beneldopa (Benserazide/levodopa) · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Safinamide versus Co-beneldopa (Benserazide/levodopa): national items dispensed by month
▬ Safinamide · ╌ Co-beneldopa (Benserazide/levodopa)
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Safinamide | Co-beneldopa (Benserazide/levodopa) |
|---|---|---|
| Items, March 2026 | 3,967 | 79,414 |
| Items, last 12 months | 45,072 | 949,699 |
| Net ingredient cost, March 2026 | £267,913 | £886,111 |
See the full profile for Safinamide or Co-beneldopa (Benserazide/levodopa).